Jiangxi Prior Pharmaceutical

Jiangxi Prior Pharmaceutical is a specialized pharmaceutical company based in Fuzhou, China, focusing on the development and large-scale production of high-potency Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The company has established a strong reputation in the oncology sector, particularly for treatments targeting prostate cancer and various solid tumors. Jiangxi Prior Pharmaceutical operates state-of-the-art manufacturing facilities that comply with international GMP standards, enabling them to serve as a key CDMO partner for global pharmaceutical firms. Their technical expertise includes complex multi-step synthesis and the handling of hazardous or highly potent compounds. By integrating R&D with commercial-scale production, the company supports the entire lifecycle of small molecule drug development.